Head of European Market Access – Oncology (Solid Tumors)
Core
Drive pricing, reimbursement, health technology assessment, and patient access strategies for Summit's oncology portfolio across Europe.
Role type
Senior European Market Access Leader (Oncology)
Builds
Sustainable pricing and reimbursement outcomes for innovative oncology therapies in Europe
Domain
Biopharmaceuticals / Oncology / European Healthcare Systems
Required skills
European market access strategy, solid tumor oncology expertise (NSCLC, CRC, bladder/urothelial), HTA framework knowledge (AMNOG, NICE, HAS, AIFA), pricing and reimbursement strategy, health economic modeling, stakeholder management with payers and HTA bodies, clinical trial design input, evidence generation strategy
Preferred skills
Experience in EU5 markets, knowledge of EU HTA Regulation, managed entry agreements, outcomes-based contracts, real-world evidence strategies
Technologies
AMNOG, G-BA, IQWiG, HAS, NICE, AIFA, CEPS, SMC, GKV-Spitzenverband, Transparency Committee, SMR/ASMR, EU HTA Regulation
Responsibilities
Develop and execute integrated European market access strategy; Lead access planning across EU5 and additional strategic markets; Translate global pricing objectives into country-specific strategies; Lead development of pricing, reimbursement, and HTA strategies; Partner with Clinical Development and Medical Affairs to integrate payer requirements into trial design; Guide European evidence generation to strengthen value propositions
Seniority
Senior, strategic leadership with hands-on execution